The Post-Pandemic Life Sciences Landscape: How a crisis enabled innovation, collaboration and a new way forward
Ina Fassbender/Agence France Presse via Getty Images Life sciences researchers, industry and regulators responded to the COVID-19 pandemic not only with urgency but with cooperation, innovative trial designs and new technologies and approaches that could reshape work across the industry – but it will take effort and intention to ensure these changes endure past the crisis, according to experts who joined “The Post-Pandemic Life Sciences Landscape,” a roundtable hosted by SmartBrief. Decentralized trials, hybrid approaches and remote monitoring were talked about fondly and frequently bef...